Company intelligence / Profile preview

Engage Biologics

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

Engage Biologics is a medical technology company focused on developing next-generation regenerative biologics for the orthopedic and spine markets. The company's core technology centers on advanced synthetic bone graft substitutes, including bioactive glass fibers designed to optimize bone healing and surgical handling. By leveraging innovative material science, Engage Biologics provides surgeons with high-performance solutions for complex bone regeneration challenges. The company is headquartered in Salt Lake City, Utah, and operates within the rapidly evolving musculoskeletal biologics sector.

Therapeutic areas: RheumatologyOther
Modalities: BiologicDeviceSynthetic bone graft
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Engage Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Engage Biologics.

Explore the full profile